Abstract
Our aim was to study anatomical and molecular changes at varying time points after the induction of cavernosal ischemia (CI) in a rabbit model of arteriogenic erectile dysfunction. Tissue structure and the expression of angiogenic and neurogenic genes were examined using immunostaining and reverse transcription-polymerase chain reaction (RT-PCR) analyses. We found a progressive increase of erectile connective tissue together with a decrease in smooth muscle cell content as the duration of CI increased. Immunohistochemical staining showed an increase in vascular endothelial growth factor (VEGF) levels at the early stages and a decrease at the later stages of ischemia. RT-PCR analysis of VEGF and neuronal nitric oxide synthase (nNOS) confirmed these results and showed nearly a two-fold increase in VEGF and nNOS mRNA levels in the early stages of CI with a decrease at the later stages of CI. On the other hand, mRNA levels of VEGF receptor, KDR, decreased approximately by 50% over the course of CI. Our studies showed that the cellular and molecular responses of the erectile tissue to short-term ischemia are different than those seen after long-term ischemia. The dramatic reduction in KDR expression suggests that the cavernosal endothelium is very sensitive to ischemia. The similar changes in VEGF and nNOS expression over the course of CI suggest a tissue-defensive mechanism to CI via the VEGF and NO pathways. Taken together, this study suggests that supplementation of VEGF at earlier stages of ischemia may restore the damaged endothelial cells of the corpus cavernosum and support tissue perfusion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levine FJ, Greenfield AJ, Goldstein I . Arteriographically determined occlusive disease within the hypogastric-cavernous bed in impotent patients following blunt perineal and pelvic trauma. J Urol 1990; 144: 1147–1153.
Rosen MP et al. Arteriogenic impotence: findings in 195 impotent men examined with selective internal pudendal angiography. Radiology 1990; 174: 1043–1048.
Sattar AA et al. Cavernous oxygen tension and smooth muscle fibers: relation and function. J Urol 1995; 154: 1736–1739.
Azadzoi KM et al. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997; 157: 1011–1017.
Gonzalez-Cadavid NF, Ignarro LJ, Rajfer J . Nitric oxide and the cyclic GMP system in the penis. Mol Urol 1999; 3: 51–59.
Lee MC et al. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761–767.
Moreland RB et al. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826–834.
Lin CS et al. Vascular endothelial growth factor induces IP-10 chemokine expression. Biochem Biophys Res Commun 2002; 292: 79–82.
Folkman J, D'Amore PA . Blood vessel formation: what is its molecular basis? Cell 1996; 87: 1153–1155.
Ferrara N . Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77: 527–543.
Dvorak HF et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97–132.
van der Zee R et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030–1037.
Seyam RM, Huynh HT, Brock GB . Neuronal and endothelial nitric oxide synthase isoforms: quantification of protein and mRNA in the normal rat penis. Int J Impot Res 1999; 11: 301–308.
Claesson-Welsh L . Signal transduction by vascular endothelial growth factor receptors. Biochem Soc Trans 2003; 31: 20–24.
Feng D et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000; 48: 545–556.
Moreland RB, Gupta S, Goldstein I, Traish A . Cyclic AMP modulates TGF-beta 1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 1998; 10: 159–163.
Azadzoi KM et al. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160: 2216–2222.
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of Massachusetts male Aging Study. J Urol 1994; 151: 54–61.
Kim JH et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth cell dysfunction. J Urol 1994; 151: 198–205.
Marti HJ et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000; 156: 965–976.
Zhang ZG et al. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res 1994; 654: 85–95.
Border WA, Noble NA . Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286–1292.
Nehra A et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998; 159: 2229–2236.
Dimmeler S, Zeiher AM . Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000; 87: 434–439.
Shima DT, Deutsch U, D'Amore PA . Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995; 370: 203–208.
Semenza GL . Angiogenesis in ischemic and neoplastic disorders. Ann Rev Med 2003; 54: 17–28.
Soker S et al. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol 2001; 159: 651–659.
Benjamin LE, Keshet E . Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94: 8761–8766.
Rogers RS et al. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26–37.
Byrne RR et al. Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol 2001; 165: 1310–1315.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by: Veterans Affairs Central Office and NIH NIA/AG17165.
Rights and permissions
About this article
Cite this article
Wang, T., Soker, S., Atala, A. et al. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int J Impot Res 16, 403–411 (2004). https://doi.org/10.1038/sj.ijir.3901186
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901186
Keywords
This article is cited by
-
Analysis of pomegranate juice components in rat corpora cavernosal relaxation
International Journal of Impotence Research (2014)
-
Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?
Journal of Translational Medicine (2013)
-
Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED
International Journal of Impotence Research (2012)
-
Implications of Vascular Endothelial Growth Factor for Postischemic Neurovascular Remodeling
Journal of Cerebral Blood Flow & Metabolism (2009)